MNKD
MannKind Corp
NASDAQ: MNKD · HEALTHCARE · BIOTECHNOLOGY
$2.75
-1.43% today
Updated 2026-04-29
Market cap
$849.19M
P/E ratio
137.50
P/S ratio
2.43x
EPS (TTM)
$0.02
Dividend yield
—
52W range
$2 – $7
Volume
6.3M
MannKind Corp (MNKD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
1.68%
Operating margin
-6.87%
ROE
0.00%
ROA
4.91%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $100000.00 | $-230.55M | 100.00% | -233,697.00% | -230,548.00% |
| 2007 | $10000.00 | $-293.19M | 100.00% | -3,073,570.00% | -2,931,900.00% |
| 2008 | $20000.00 | $-303.04M | 100.00% | -1,528,825.00% | -1,515,195.00% |
| 2009 | — | $-220.10M | — | — | — |
| 2010 | $93000.00 | $-170.56M | 100.00% | -163,976.34% | -183,397.85% |
| 2011 | $50000.00 | $-160.80M | 100.00% | -281,078.00% | -321,608.00% |
| 2012 | $35000.00 | $-169.37M | 100.00% | -419,885.71% | -483,902.86% |
| 2013 | $3.17M | $-191.49M | — | -5,350.63% | -6,048.33% |
| 2014 | $0.00 | $-198.38M | — | — | — |
| 2015 | $0.00 | $-368.44M | — | — | — |
| 2016 | $174.76M | $125.66M | 71.34% | 38.49% | 71.91% |
| 2017 | $11.74M | $-117.33M | -46.68% | -921.15% | -999.00% |
| 2018 | $27.86M | $-86.97M | 26.49% | -274.94% | -312.20% |
| 2019 | $63.04M | $-51.90M | 55.62% | -70.75% | -82.34% |
| 2020 | $65.14M | $-57.24M | 62.17% | -73.55% | -87.87% |
| 2021 | $75.44M | $-80.93M | 48.49% | -62.33% | -107.27% |
| 2022 | $99.77M | $-87.40M | 42.37% | -64.26% | -87.60% |
| 2023 | $198.96M | $-11.94M | 68.45% | 4.36% | -6.00% |
| 2024 | $285.50M | $27.59M | 73.17% | 25.42% | 9.66% |
| 2025 | $348.97M | $5.86M | 82.47% | 11.12% | 1.68% |